![]() | |
Clinical data | |
---|---|
Trade names | Sanvar |
Other names | H-D-Phe-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Trp-NH2 Octastatin |
ATC code | |
Pharmacokinetic data | |
Eliminationhalf-life | 30 minutes |
Identifiers | |
| |
CAS Number | |
PubChemCID | |
PubChem SID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C57H70N12O9S2 |
Molar mass | 1131.38 g·mol−1 |
3D model (JSmol) | |
Density | 1.4 g/cm3 |
Boiling point | 1,540.9 °C (2,805.6 °F) |
| |
|
Vapreotide (Sanvar) is a syntheticsomatostatin analog. It is used in the treatment ofesophageal variceal bleeding[1][2] in patients with cirrhoticliver disease andAIDS-relateddiarrhea.[3]
It is an 8 residue peptide with sequence H-D-Phe-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Trp-NH2.
![]() | Thishormonal preparation article is astub. You can help Wikipedia byexpanding it. |